Sophion partners with Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, to enable standardized integration between Sophion APC platforms and Genedata Screener.
 "Plant cell electrophysiology on QPatch II")
Plant cell electrophysiology on QPatch II
Internship poster presents plant cell ion channel recordings on QPatch II
 "Q2 sees a bumper crop of 15 publications using Qube 384 and QPatch")
Q2 sees a bumper crop of 15 publications using Qube 384 and QPatch
Research on neuroinflammation, cancer, amnesia, chronic pain, epilepsy, anti-bacterials & diabetes; two Sophion authored papers; two more U. Queensland venom toxin papers
 "Global academic-industry collaboration developing anti-venom antibodies")
Global academic-industry collaboration developing anti-venom antibodies
DTU researchers discuss their latest findings in developing antibodies to neutralize snake venom toxins
 "New Whitepaper: Automated Patch Clamp in Cystic Fibrosis Drug Discovery")
New Whitepaper: Automated Patch Clamp in Cystic Fibrosis Drug Discovery
A case study on how Enterprise Therapeutics successfully applied automated patch clamp in primary screening and lead optimization in its TMEM16A drug discovery programme
 "Sophion and Genedata announces integration of QPatch II and Qube 384 data to Genedata Screener")
Sophion and Genedata announces integration of QPatch II and Qube 384 data to Genedata Screener
Full integration of Qube 384 and QPatch II data to Genedata Screener will ensure that APC data can be analyzed in a screening context, i.e., integrated with molecule and assay property information, scaling from one to hundreds of plates per batch.
 "Two cardiac publications authored by Sophion scientists")
Two cardiac publications authored by Sophion scientists
Sophion Japan collaborated with Toho University on Oseltamivir an anti-afibrillatory; a review of APC in cardiac safety assessment.
